Alaunos Therapeutics, Inc. (TCRT) Tops Q4 EPS by 1c
Get Alerts TCRT Hot Sheet
Join SI Premium – FREE
Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue
- Ross Stores raises 2026 outlook after strong second-quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share